| No. | Document Title | ID | Updated | Views |
|---|---|---|---|---|
| 321 | Modalities | 101818 | 2022-12-02 | 427 |
| 322 | Arm Description | 101817 | 2022-12-02 | 572 |
| 323 | Arm Code | 101816 | 2022-12-02 | 443 |
| 324 | Arm | 101815 | 2022-12-02 | 486 |
| 325 | Step Type | 101814 | 2022-12-02 | 350 |
| 326 | Step | 101813 | 2022-12-02 | 357 |
| 327 | Exempt (if applicable) | 101811 | 2022-12-02 | 336 |
| 328 | Expanded Access Status | 101810 | 2022-12-02 | 350 |
| 329 | Expanded Access | 101809 | 2022-12-02 | 379 |
| 330 | IND/IDE: Expiration Date | 101807 | 2022-12-02 | 363 |
| 331 | FDA Approval Date | 101806 | 2022-12-02 | 387 |
| 332 | IND/IDE Submit Date | 101805 | 2022-12-02 | 317 |
| 333 | Grantor | 101804 | 2022-12-02 | 317 |
| 334 | NCI/NIH Institution | 101803 | 2022-12-02 | 330 |
| 335 | Investigational Drug/Device | 101800 | 2022-12-02 | 326 |
| 336 | Fund Account No. | 101797 | 2022-11-29 | 493 |
| 337 | Sponsor Protocol No. | 101796 | 2022-11-29 | 354 |
| 338 | Sponsor Type | 101795 | 2022-11-29 | 400 |
| 339 | Managment Group | 101788 | 2022-11-29 | 395 |
| 340 | Toxicity Scheme | 24235 | 2022-11-25 | 489 |
Not finding what you are looking for? Suggest a new document be created, or try searching again with multiple search terms.